Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:COVID-19
|
| gptkbp:alsoKnownAs |
B.1.621
VOI Mu |
| gptkbp:class |
gptkb:World_Health_Organization
Variant of Interest |
| gptkbp:discoveredBy |
gptkb:Colombia
January 2021 |
| https://www.w3.org/2000/01/rdf-schema#label |
Mu variant
|
| gptkbp:impact |
increased transmissibility
reduced vaccine effectiveness |
| gptkbp:lineage |
B.1.621
|
| gptkbp:mutationAssociatedWith |
gptkb:D614G
gptkb:E484K gptkb:N501Y P681H R346K Y144T Y145S |
| gptkbp:parentVirus |
gptkb:COVID-19
|
| gptkbp:spreadTo |
gptkb:Europe
gptkb:North_America gptkb:South_America |
| gptkbp:statusAsOf2023 |
not classified as Variant of Concern
|
| gptkbp:WHODesignationDate |
August 2021
|
| gptkbp:bfsParent |
gptkb:COVID-19
|
| gptkbp:bfsLayer |
4
|